Introduction
Leishmaniasis is an arthropod borne zoonotic disease transmitted through the bites of female sandflies. The old world leishmaniasis is caused principally by Leishmania donovani(L. donovani), Leishmania infantum (L. infantum), Leishmania tropica(L. tropica), Leishmania majoy (L. major) and Leishmania aethiopica(L. aethiopica )are transmitted by Phlebotomus species while parasites of the new world infections principally Leishmania peruriana (L. peruriana), Leishmania chagasi (L. chagasi), Leishmania mexicaca (L. mexicaca) complex and Leishmania braziliensis (L. braziliensis) complex are transmitted by sandflies of the genus Lutzomyia and Psychodopygus [1, 2] . Leishmaniasis is broadly grouped into cutaneous, mucocutaneous and visceral types in line with the clinical manifestation of each infection. Cutaneous leishmaniasis is commonly caused by L. tropica, L. major, L. aethiopica, L. mexicana complex, L. braziliensis and L. peruviana while visceral leishmaniasis is caused by L. donovani, L. infantum which causes infantile visceral leishmaniasis and L. chagasi that causes the American type [3, 4] .
There have been several reports of unusual clinical presentations of cutaneous leishmaniasis which often put to test both the clinical and laboratory competence of the management teams involved. Apart from presenting as pyrexia of unknown origin with attendant difficulties in diagnosis especially in climes where the disease is barely known, and also as tuberculous granulomatous skin lesions and non infectious sarcoid lesions, the disease may as well present with features mimicking malignant tumours [5] [6] [7] . In the present era of AIDS, leishmaniasis has also been found to be proportionately on the increase where the prevalence of AIDS is also high with more of its unusual clinical features expected [8] [9] [10] .
In view of the present global upsurge in the incidence of Cutaneous leishmaniasis is regarded as a re-emerging disease due to its increase in spread and rate of transmission over the past decade due to a proportionate increase in global human movements. This study was therefore carried out to review epidemiology, laboratory diagnosis and treatment with in-depth discussion on some of the rare clinical presentations of the disease capable of influencing its control. The study was based on literature review on clinical and laboratory features of cutaneous leishmaniasis from original research articles, review articles, short communications, letters to editor and case reports on the disease for the past 10 years (April 2000 to April 2010). The results were analysed using simple descriptive methods. The rarest presentations of leishmaniasis encountered were peritibial ulcerations, hard painful nipple in a male, swollen upper lip, dermatofibro sarcoma protuberans, sternal proliferative growth, turban tumour, post operative granuloma, chalazion-like 0.00%, and cutaneous sterile pyogranuloma with asymmetrical alopecia 0.00% each. Others include infected sebaceous cysts 0.45%, syphilis 0.19%, yaws 0.13%, thrombotic ulcerations 0.40%, mycetoma 0.90%, sarcoidosis 0.67%, painless nasal solitary nodule 0.00%, tuberculous lymphadenopathy 0.25% and unilateral erythema nodosum 0.28%. Physicians practicing in cutaneous leishmaniasis endemic, but most especially in the non-endemic areas should bear in mind that the disease may not be that rare in the context of the present global village phenomenon; and that, the next case could just be that of cutaneous leishmaniasis, the clinical picture of the patient notwithstanding.
cutaneous leishmaniasis with accompanying challenging clinical features, the disease could no doubt be classified as a re-emerging disease. This study was therefore set up to review the epidemiology, laboratory diagnosis and treatment of cutaneous leishmaniasis with in-depth discussion on unusual clinical presentations of the disease from available literatures on the disease in the tropical and sub-tropical parts of the world. This is to help raise the index of suspicion among clinicians who may be confronted with its myriad of complex clinical presentations [11] [12] [13] . It is estimated that at least 14 million people globally are currently infected by Leishmania parasites in not less than 82 countries. The annual infection rate is put at 2 million while at least 350 million (5.0%) of the world's estimated 7 billion people are still at risk of acquiring leishmaniasis [14, 15] . Also there are presently at least 1.5 million new cases of cutaneous leishmaniasis alone each year. The disease is common in central Asia, Middle East, Indian sub-continent, Africa especially around Ethiopia, Eritrea and Somalia, Central America and western Peru [16] [17] [18] .
The classical clinical picture of cutaneous leishmaniasis is the formation of raised papules leading to formation of ulcers with clean cut margins and raised indurated edges called sores with accompanying varying degrees of immunosupression [19, 20] . Post Kala-azar dermal leishmaniasis (PKDL) is caused by L. donovani, a causative agent of visceral leishmaniasis after about two years of treatment for the original disease. It presents as hypopigmented macules and indurations anywhere in the body especially the upper trunk [20] [21] [22] .
Laboratory diagnosis of cutaneous leishmaniasis is by detection of the amastigote forms of the parasites in macrophages from material obtained by puncture of indurated edge of the sore and stained by Wright or Giemsa stains. Promastigotes of the parasites may also be recovered from Novile Nicole Mc Neil (NNN), Hockmeyer's or Schneider's insect culture media inoculated with ulcer aspirates. The leishmanin skin test based on intradermal injection of leishmanin (killed promastigotes of L. tropica in 0.5% phenol saline) is also sensitive and specific [24, 25] . PKDL is diagnosed by microscopical examination of amastigote form of L. donovani by Leishman-stained smears of biopsy material from a nodular lesion [24] [25] [26] . Other diagnostic methods include: nested polymerase chain reaction (PCR), restriction fragment length polymorphism (RFLP) and other molecular methods, histology and cytology, chromatographic and immunohistochemical procedures [25, 26] .
Leishmania parasites respond well to several antimicrobial agents, these include: pentavelent antimonials (sodium stibogluconate, megbumine antimoniate), aromatic derivatives (pentamidine), and other drugs such as monomycin, paromomycin, amonosidine, amphotericin B and allopurinol [26] .
Clinical presentation of cutaneous leishmaniasis
From 6 689 cases of cutaneous leishmaniasis in 778 literature reviews studied, 76.80% (5 135) presented with classical cutaneous features of papules, nodules and ulcers while 23 .20% (1 554) presented with unusual features.
The less common modes of presentation of cutaneous leishmaniasis were as: pyrexia of unknown origin (PUO) 5.19% (347), Non-specific cutaneous granulomatous dermatoses 1.17% (78), cutaneous myiasis 2.16% (145), mycetoma 0.90% (64) and lymphoproliferative malignancies 0.99 (66) and post kala azar dermal leishmaniasis (PKDL) 3.09% (207) ( Table 1 ).
The most rare presentations of cutaneous leishmaniasis encountered were peritibial ulcerations, hard painful nipple in a male, swollen upper lip, dermatofibro sarcoma protuberans, sternal proliferative growth, turban tumour, post operative granuloma and cutaneous sterile pyogranuloma with asymmetrical alopecia 0.00% each (1-2) ( Table 1) .
Other unusual presentations of cutaneous leishmaniasis were chalazion-like 0.14% (10), infected sebaceous cysts 0.47% (32), syphilis 0.19% (13), yaws 0.13% (9), thrombotic ulcerations 0.40% (27) , multiple myeloma 0.46% (31), sarcoidosis 0.67% (17), painless nasal solitary nodule 0.00% (2), tuberculous lymphadenopathy 0.25% (11) , and unilateral erythema nodosum 0.28% (19) ( Table 1 ).
Unusual clinical presentations of cutaneous leishmaniasis
The most unusual clinical presentations of cutaneous leishmaniasis presently documented are: peritibial ulcerations, hard painful nipple in a male, swollen upper lip, dermatofibro sarcoma protuberans, sternal proliferative growth, turban tumour, post operative granuloma and cutaneous sterile pyogranuloma with asymmetrical alopecia 0.00% (<5) each. Similarly, chalazion-like 0.00%, infected sebaceous cysts 0.47%, syphilis 0.19%, yaws 0.13%, thrombotic ulcerations 0.40%, multiple myeloma 0.46%, sarcoidosis 0.67%, painless nasal solitary nodule 0.00%, tuberculous lymphadenopathy 0.25% and unilateral erythema nodosum 0.28% were other rare clinical pictures of cutaneous leishmaniasis. This is in addition to the usual classical presentations of the disease which were found in 76.80% of cases as well as presentations as PKDL and as PUO. Fever, headache, weight loss, loss of appetite and varying haematological abnormalities were common features associated with various forms of presentation.
The association of symptoms such as fever, headache, weight loss and loss of appetite may delay or make diagnosis of the disease difficult especially in most tropical and subtropical regions of the world where several other infectious diseases such as malaria, typhoid, tuberculosis and human immunodeficiency virus (HIV) are still common and often present with similar symptoms as cutaneous leishmaniasis [27] [28] [29] . The disease may become more difficult in diagnosis in isolated imported cases occasioned by easy global integration and movement, and where index of suspicion may be extremely low among the local clinicians due to its absence in some communities [30] [31] [32] . Presentations in form of PUO and PKDL which were found to be common in India and Pakistan may even be more confusing where clinical history may not link with any immediate source of the infection hence making its early and immediate diagnosis difficult [32] [33] [34] .
Leishmaniasis has been found to create varying degrees of diagnostic dilemmas in different parts of the world: in Canada, leishmaniasis was found to present as cutaneous myiasis caused by Dermatobia hominis [34] ; in Tunisia, erythema nodosum was the presenting feature [35] ; while in Brazil, pyrexia of unknown origin (PUO) were found to be common presentations [36] . Also in USA, cutaneous leishmaniasis was found to present as sebaceous cysts [37] , and as boggy induration mimicking malignancy [38] ; while in the Netherlands, the disease was found to mimic buruli ulcers from immigrants [39] . The presentation of leishmaniasis as chalazion in Iran [40] , mycetoma in India [41] , and as a post-operative granuloma in Scotland [42] all constituted varying difficulties arriving at the exact diagnosis with delays in proper management of the patients.
The main factors responsible for the delays or difficulties in arriving at the diagnosis of cutaneous leishmaniasis from the various studies were usually as a result of the presentations mimicking other diseases known for such presentations, and also the fact that, the amastigotes forms of the parasites were difficult to detect in several cases on microscopy [43] [44] [45] . In other instances of diagnostic dilemma of cutaneous leishmaniasis, genetic methods such as PCR and RFLP still failed to establish diagnosis of cutaneous leishmaniasis until therapeutic trials were commenced which turned out to be the way forward [46, 47] . The fact is that in classical cases of cutaneous leishmaniasis, parasites may be detected by microscopy or histology of biopsy specimens in less than 70% of cases [48, 49] . The finding of some of these cases in areas where leishmaniasis was rare or scarcely a public health issue further contributed to the difficulty in arriving at diagnosis [50] [51] [52] .
In view of the present global mass or individual movement of people and the increasing transmission of leishmaniasis, the disease is no doubt re-emerging with probably no territorial or geographical boundaries. Physicians practicing in regions where the disease is unknown or rare should consider it a possible encounter at any time in the course of their practice.
Adequate facilities for laboratory diagnosis of leishmaniasis as well as that of other emerging diseases should be provided at clinics and hospitals especially in the developing world; these include histology/cytology, immunohistochemistry, polymerase chain reaction (PCR) and other genetic methods, culture and microscopy, so as to shorten the time and lighten the clinical and laboratory rigour towards arriving at definitive diagnosis. Regional governments should be sensitised towards influencing health policies so as to achieve these goals.
In patients presenting with PUO where amastigotes prove difficult to detect with all available laboratory facilities, therapeutic trial should be considered a veritable treatment option. Physicians should always be aware and conscious of this fact. Physicians may need to look, and look again when carrying out physical examination of even very familiar cutaneous lesions and accommodate as many possibilities as possible especially in the present global changes in epidemiology of diseases.
The authors wish to note that the data presented on cutaneous leishmaniasis in the present study is subject to certain variables and may not represent the most accurate up to date information on the disease. These include underdiagnosis of the disease due to probably poor infrastructure from the developing world, under-reporting from health institutions due to varying degrees of competence in data management, unwillingness or inability to publish scientific findings, and also authors' preference of specific data on the disease to present with greater clarity and accuracy in journal articles. These limitations are nevertheless well noted and should also be considered in the utilization of this piece of clinical information.
Conclusion
The present study has shown that cutaneous leishmaniasis, in its myriad of unusual presentations are capable of confusing the most experienced physicians. Physicians therefore, while attending to patients with simple and often common cutaneous lesions should as well broaden their thoughts to accommodate possibly both immediate and remote possibilities such as cutaneous leishmaniasis so as to forestall probable ophthalmic, medical as well as surgical pitfalls.
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